Abstract
We showed previously that exogenous overexpression of C3G, a guanine nucleotide releasing factor (GEF) for Rap1 and R-Ras proteins, blocks the focus-forming activity of cotransfected, activated, sis, ras and v-raf oncogenes in NIH 3T3 cells. In this report, we show that C3G also interferes with dbl and R-Ras focus-forming activity and demonstrate that the transformation suppressor ability of C3G maps to its Crk-binding region (SH3-b domain). Using full-length C3G and C3GΔCat mutant, lacking catalytic domain, we showed here that overexpression of cotransfected C3G or C3GΔCat inhibited oncogenic Hraslys12-mediated phosphorylation of ERK, without altering Ras and Raf-1 kinase activation. We also showed that, overexpressed C3G and C3GΔCat inhibited the viability of oncogenic Ras-induced colonies in soft agar, indicating that C3G interferes with the anchorage-independent growth of Ras-transformed cells in a Rap1-independent manner. Consistent with both observations, overexpression of exogenous C3G and C3GΔCat also caused downregulation of Ras-induced cyclin A expression. Altogether, our results indicate that C3G interferes with at least two separate aspects of oncogenic transformation – cell cycle progression and loss of contact inhibition – and that these inhibitory effects probably account for its transformation suppressor activity.
Similar content being viewed by others
References
Abassi YA and Vuori K . (2002). EMBO J., 21, 4571–4582.
Arai A, Nosaka Y, Kanda E, Yamamoto K, Miyasaka N and Miura O . (2001). J. Biol. Chem., 276, 10453–10462.
Arai A, Nosaka Y, Kohsaka H, Miyasaka N and Miura O . (1999). Blood, 93, 3713–3722.
Benito M, Porras A, Mebreda MA and Santos E . (1991). Science, 253, 565–568.
Chen L and Okayama H . (1987). Mol. Cell. Biol., 7, 2745–2752.
de Jong R, van Wijk A, Heisterkamp N and Groffen J . (1998). Oncogene, 17, 2805–2810.
Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H and Kolch W . (2002). Mol. Cell. Biol., 22, 3237–3246.
DiFiore PP, Pierce JH, Kraus MH, Segatto O, King CR and Aaronson SA . (1987). Science, 237, 178–183.
Eva A and Aaronson SA . (1985). Nature, 316, 273–275.
Gotoh T, Hattori S, Nakamura S, Kitayama H, Noda M, Takai Y, Kaibuchi K, Matsui H, Hatase O, Takahashi H, Kurata T and Matsuda M . (1995). Mol. Cell. Biol., 15, 6746–6753.
Gotoh T, Niino Y, Tokuda M, Hatase O, Nakamura S, Matsuda M and Hattori S . (1997). J. Biol. Chem., 272, 18602–18607.
Guadagno TM, Ohtsubo M, Roberts JM and Assoian RK . (1993). Science, 262, 1572–1575.
Guerrero C, Fernández-Medarde A, Rojas JM, Font de Mora J, Esteban LM and Santos E . (1998). Oncogene, 16, 613–624.
Guerrero C, Pesce L, Lecuona E, Ridge KM and Sznajder JI . (2002). Am. J. Physiol., 282, L1099–L1107.
Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ and Counter CM . (2002). Genes Dev., 16, 2045–2057.
Howe A, Aplin AE, Alahari SK and Juliano RL . (1998). Curr. Opin. Cell Biol., 10, 220–231.
Ishimaru S, Williams R, Clark E, Hanafusa H and Gaul U . (1999). EMBO J., 18, 145–155.
Kang JS and Krauss RS . (1996). Mol. Cell. Biol., 16, 3370–3380.
Knudsen BS, Feller SM and Hanafusa H . (1994). J. Biol. Chem., 269, 32781–32787.
Lacal JC and Aaronson SA . (1986). Proc. Natl. Acad. Sci. USA, 83, 5400–5404.
Li L, Okura M and Imamoto A . (2002). Mol. Cell. Biol., 22, 1203–1217.
Marais R, Light Y, Paterson HF and Marshall CJ . (1995). EMBO J., 14, 3136–3145.
Matter ML and Laurie GW . (1994). J. Cell. Biol., 124, 1083–1090.
McLeod SJ, Ingham RJ, Bos JL, Kurosaki T and Gold MR . (1998). J. Biol. Chem., 273, 29218–29223.
Miki T, Matsui T, Heidaran MA and Aaronson SA . (1989). Gene, 83, 137–146.
Mochizuki N, Ohba Y, Kobayashi S, Otsuka N, Graybiel AM, Tanaka S and Matsuda M . (2000). J. Biol. Chem., 275, 12667–12671.
Ohba Y, Ikuta K, Ogura A, Matsuda J, Mochizuki N, Nagashima K, Kurokawa K, Mayer BJ, Maki K, Miyazaki J and Matusda M . (2001). EMBO J., 20, 3333–3341.
Ohba Y, Mochizuki N, Yamashita S, Chan AM, Schrader JW, Hattori S, Nagashima K and Matsuda M . (2000). J. Biol. Chem., 275, 20020–20026.
Paasinen-Sohns A and Holtta E . (1997). Oncogene, 15, 1953–1966.
Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA and Ewen ME . (1997). Nature, 386, 177–181.
Quilliam LA, Rebhun JF and Castro AF . (2002). Prog. Nucleic Acid Res. Mol. Biol., 71, 391–444.
Reedquist KA and Bos JL . (1998). J. Biol. Chem., 273, 4944–4949.
Renshaw MW, Ren XD and Schwartz MA . (1997). EMBO J., 16, 5592–5599.
Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J . (1997). Cell, 89, 457–467.
Saez R, Chan AM-L, Miki T and Aaronson SA . (1994). Oncogene, 9, 2977–2982.
Sakkab D, Lewitzky M, Posern G, Schaeper U, Sachs M, Birchmeier W and Feller SM . (2000). J. Biol. Chem., 275, 10772–10778.
Sakoda T, Kaibuchi K, Kishi K, Kishida S, Doi K, Hoshino M, Hattori S and Takai Y . (1992). Oncogene, 7, 1705–1711.
Schulze A, Zerfass-Thome K, Berges J, Middendorp S, Jansen-Durr P and Henglein B . (1996). Mol. Cell. Biol., 16, 4632–4638.
Sozeri O, Vollmer K, Liyanage M, Frith D, Kour G, Mark GE and Stabel S . (1992). Oncogene, 7, 2259–2262.
Takuwa N and Takuwa Y . (2001). Mol. Cell. Endocrinol., 177, 25–33.
Tanaka S, Morishita T, Hashimoto Y, Hattori S, Nakamura S, Shibuya M, Matuoka K, Takenawa T, Kurata T and Nagashima K . (1994). Proc. Natl. Acad. Sci. USA, 91, 3443–3447.
Uemura N and Griffin JD . (1999). J. Biol. Chem., 274, 37525–37532.
Voss AK, Gruss P and Thomas T . (2003). Development, 130, 355–367.
Yam CH, Fung TK and Poon RY . (2002). Cell. Mol. Life Sci., 59, 1317–1326.
Yang J-J, Kang J-S and Krauss RS . (1998). Mol. Cell. Biol., 18, 2586–2595.
Yokote K, Hellman U, Ekman S, Saito Y, Rönnstrand L, Saito Y, Heldin C-H and Mori S . (1998). Oncogene, 16, 1229–1239.
York DR, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW and Stork PJS . (1998). Nature, 392, 622–626.
Zhu T, Goh ELK, LeRoith D and Lobie PE . (1998). J. Biol. Chem., 273, 33864–33875.
Acknowledgements
This work was supported by grants SAF00-0069 from MCYT and PI021570 from FIS, Spain. CG was supported by the Ramón y Cajal Program from MCYT.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guerrero, C., Martín-Encabo, S., Fernández-Medarde, A. et al. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth. Oncogene 23, 4885–4893 (2004). https://doi.org/10.1038/sj.onc.1207622
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207622
- Springer Nature Limited
Keywords
This article is cited by
-
Identification and functional validation of SRC and RAPGEF1 as new direct targets of miR-203, involved in regulation of epidermal homeostasis
Scientific Reports (2023)
-
C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells
Cell Death & Disease (2021)
-
C3G Regulates STAT3, ERK, Adhesion Signaling, and Is Essential for Differentiation of Embryonic Stem Cells
Stem Cell Reviews and Reports (2021)
-
C3G contributes to platelet activation and aggregation by regulating major signaling pathways
Signal Transduction and Targeted Therapy (2020)
-
Expression of a novel brain specific isoform of C3G is regulated during development
Scientific Reports (2020)